Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Diseases

Free Subscription Articles published in Dig Dis Sci Retrieve available abstracts of 163 articles: HTML format

Single Articles

June 2025
1. LI R, Lee S, Caldwell PC, Tsavaris KL, et al
   In-Hospital Outcomes of Patients with Hepatorenal Syndrome Who Underwent Transjugular Intrahepatic Portosystemic Shunt Procedure.
   Dig Dis Sci. 2025 Jun 11. doi: 10.1007/s10620-025-09130.
   PubMed     Abstract available
   
   
   
2. BELCHER JM
   Predicting the Use of Dialysis for Acute Kidney Injury in Patients with Cirrhosis-Does Diagnosis Matter?
   Dig Dis Sci. 2025 Jun 5. doi: 10.1007/s10620-025-09143.
   PubMed    
   
   
   May 2025
3. OWAIS M, Kumar D, Anjum A, Kumar J, et al
   Clinical Insights on Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
   Dig Dis Sci. 2025 May 31. doi: 10.1007/s10620-025-09124.
   PubMed    
   
   
   
4. DE CARVALHO MS, Ferreira CN
   Hot TIPS-Success of Transjugular Intrahepatic Portosystemic Shunt in Patients with Cavernous Transformation of the Portal Vein.
   Dig Dis Sci. 2025 May 20. doi: 10.1007/s10620-025-09087.
   PubMed    
   
   
   
5. JALIL S, Mumtaz K
   Heart of the Matter: Uncovering the Link Between Heart Failure and Cirrhosis Mortality.
   Dig Dis Sci. 2025 May 19. doi: 10.1007/s10620-025-09092.
   PubMed    
   
   
   
6. PASTA A, Pieri G, Plaz Torres MC, Missale G, et al
   Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
   Dig Dis Sci. 2025 May 3. doi: 10.1007/s10620-025-09064.
   PubMed     Abstract available
   
   
   
7. LIU Y, Mo W, Sun W, Chen J, et al
   NFAT2 Induces Tumor Cell Proliferation and Metastasis by Acting as a Transcriptional Co-activator of the TGF-beta1/SMAD Signaling Pathway and Inducing the Epithelial-Mesenchymal Transition in Liver Cancer.
   Dig Dis Sci. 2025;70:1799-1812.
   PubMed     Abstract available
   
   
   
8. CHEN F, Zhou Z, Fu J, Gao C, et al
   Selenomethionine Alleviates Alcohol-Induced Liver Injury by Inhibiting Ferroptosis.
   Dig Dis Sci. 2025;70:1779-1787.
   PubMed     Abstract available
   
   
   
9. CAPINHA F, Carvalhana S, Cortez-Pinto H
   Role of Alcohol in Steatotic Liver Disease: Impact on Patients with Cardiometabolic Risk Factors.
   Dig Dis Sci. 2025;70:1746-1756.
   PubMed     Abstract available
   
   
   April 2025
10. LAI SW
    Calcium Channel Blocker and Hepatocellular Carcinoma Risk.
    Dig Dis Sci. 2025 Apr 27. doi: 10.1007/s10620-025-09080.
    PubMed    
    
    
    
11. HOU F, Yan H, Gao C, Wang R, et al
    Regional Portal Hypertension Related to Pancreatic Cancer Surgery.
    Dig Dis Sci. 2025 Apr 25. doi: 10.1007/s10620-025-09063.
    PubMed    
    
    
    
12. ABUSULIMAN M, Dawod S, Nimri F, Jamali T, et al
    Predictive Factors of Post-ERCP Hepatic Decompensation in Patients with Cirrhosis: A Retrospective Case-Control Study.
    Dig Dis Sci. 2025 Apr 24. doi: 10.1007/s10620-025-09071.
    PubMed     Abstract available
    
    
    
13. LU R, Abuduhailili X, Li Y, Wang S, et al
    Integrated Analysis of PSMB8 Expression and Its Potential Roles in Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Apr 22. doi: 10.1007/s10620-025-09040.
    PubMed     Abstract available
    
    
    
14. YANG W, Li D, Zhang J
    Transcatheter Arterial Chemoembolization in a Patient with Complete Situs Inversus Totalis and Massive Primary Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Apr 16. doi: 10.1007/s10620-025-09035.
    PubMed    
    
    
    
15. AZIZ S, Hamid A, Shaikh A, Mansoor R, et al
    Unveiling Disparities in Heart Failure and Cirrhosis Related Mortality: CDC WONDER 1999 to 2020.
    Dig Dis Sci. 2025 Apr 10. doi: 10.1007/s10620-025-08970.
    PubMed     Abstract available
    
    
    
16. ZHU T, Wan X
    Hepatic Subcapsular Hematoma Induced by Metastatic Tumors.
    Dig Dis Sci. 2025 Apr 9. doi: 10.1007/s10620-025-09036.
    PubMed    
    
    
    
17. TAO T, Lv L, Chen J, He Y, et al
    Identification of Crosstalk Genes Between Primary Sjogren's Syndrome and Primary Biliary Cirrhosis by Transcriptome Analysis.
    Dig Dis Sci. 2025 Apr 8. doi: 10.1007/s10620-025-08917.
    PubMed     Abstract available
    
    
    
18. SINGAL AK
    Hepatocellular Carcinoma in Acute Porphyria: Incidence and Risk Factors.
    Dig Dis Sci. 2025 Apr 2. doi: 10.1007/s10620-025-09003.
    PubMed    
    
    
    
19. LEUNG CW, Tapper EB
    Food Insecurity Is Increasing and Is More Common Among Persons with Chronic Liver Disease.
    Dig Dis Sci. 2025;70:1360-1367.
    PubMed     Abstract available
    
    
    
20. SOGBE M, Hummer B, Stine JG, Lizaola-Mayo B, et al
    Advanced Liver Fibrosis Impairs Cardiorespiratory Fitness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Dig Dis Sci. 2025;70:1530-1539.
    PubMed     Abstract available
    
    
    
21. KEHAR M, Huerta-Saenz L, Strain J, Kawesa S, et al
    Challenges in Promoting Physical Activity for Managing MASLD in Canadian Children: Insights and Barriers.
    Dig Dis Sci. 2025;70:1368-1374.
    PubMed     Abstract available
    
    
    March 2025
22. TSENG HT, Liu PH, Hsu CY, Huang YH, et al
    Differential Prognostic Impact of Tumor Burden Score on Hepatocellular Carcinoma Patients with Variable Physical Performance Status.
    Dig Dis Sci. 2025 Mar 28. doi: 10.1007/s10620-025-08971.
    PubMed     Abstract available
    
    
    
23. FAN T, Zhu X, Ma X, Yin B, et al
    Severe Hyperhomocysteinemia, an Unusual Case of Liver Cirrhosis.
    Dig Dis Sci. 2025 Mar 28. doi: 10.1007/s10620-025-09006.
    PubMed    
    
    
    
24. LISSING M, Harper P, Wahlin S
    Hepatocellular Carcinoma in Acute Porphyria: Incidence and Risk Factors.
    Dig Dis Sci. 2025 Mar 26. doi: 10.1007/s10620-025-08959.
    PubMed    
    
    
    
25. TRUONG E, Alnimer L, Gornbein JA, Yang JD, et al
    Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLD.
    Dig Dis Sci. 2025 Mar 24. doi: 10.1007/s10620-025-08850.
    PubMed     Abstract available
    
    
    
26. CHO HJ, Lee E, Kim SS, Cheong JY, et al
    Impact of Antihypertensive and Lipid-Lowering Agents on Hepatocellular Carcinoma Risk in Patients with Fatty Liver Disease and Diabetes.
    Dig Dis Sci. 2025 Mar 19. doi: 10.1007/s10620-025-08935.
    PubMed     Abstract available
    
    
    
27. TSUJI Y, Namisaki T, Takaya H, Nishimura N, et al
    Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Mar 12. doi: 10.1007/s10620-025-08884.
    PubMed     Abstract available
    
    
    
28. CHEN JW, Chen PF, Li J, Duan XH, et al
    Transjugular Intrahepatic Portosystemic Shunt for Preventing Rebleeding of Esophageal Varices in Patients with Portal Cavernous Transformation.
    Dig Dis Sci. 2025 Mar 3. doi: 10.1007/s10620-025-08955.
    PubMed     Abstract available
    
    
    
29. SACHDEVA S, Vaithiyam V, Ahuja A, Reddy RT, et al
    Spontaneous Hepatoduodenal Fistula Due to Ruptured Amoebic Liver Abscess.
    Dig Dis Sci. 2025 Mar 1. doi: 10.1007/s10620-025-08924.
    PubMed    
    
    
    
30. WAIDYARATNE G, Jalil S, Liu A, Liyanarachchi S, et al
    Utility of Advanced Age as a Predictor of Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt.
    Dig Dis Sci. 2025 Mar 1. doi: 10.1007/s10620-025-08940.
    PubMed     Abstract available
    
    
    
31. JAGDISH B, Murone J, Venkat D
    Implementation of Alcohol Use Disorder Training Curriculum Improves Perceived Confidence in Treating Alcohol-Related Liver Disorder Amongst Gastroenterology Fellows.
    Dig Dis Sci. 2025;70:1000-1007.
    PubMed     Abstract available
    
    
    
32. CHIEN SC, Chiu HC, Chiu YC, Wang RH, et al
    Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD).
    Dig Dis Sci. 2025;70:1190-1200.
    PubMed     Abstract available
    
    
    
33. ZHANG J, Yang Z, Liu X, Yang X, et al
    New Insights into the Pathogenesis of Alcoholic Liver Disease Based on Global Research.
    Dig Dis Sci. 2025;70:903-918.
    PubMed     Abstract available
    
    
    
34. PIETRI O, Chicaud M, Andreani T, Chretien Y, et al
    Unexplained Chronically Elevated Aminotransferases: Liver Biopsy Gives Major Information with Therapeutic Implication in One Patient Out of Seven.
    Dig Dis Sci. 2025;70:1178-1189.
    PubMed     Abstract available
    
    
    February 2025
35. KUMAR S, Biswas S, Agarwal S, Sheikh S, et al
    Next-Generation Sequencing Identifies Novel Germline Mutations in Patients with Budd-Chiari Syndrome-Associated Hepatocellular Carcinoma.
    Dig Dis Sci. 2025 Feb 28. doi: 10.1007/s10620-025-08942.
    PubMed     Abstract available
    
    
    
36. PAK K, Sachar R, Saab S
    Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States.
    Dig Dis Sci. 2025 Feb 20. doi: 10.1007/s10620-025-08909.
    PubMed     Abstract available
    
    
    
37. LOEFFLER J, Hassan M, Qaqish F, Dimachkie R, et al
    Predictors of Renal Replacement Therapy Requirement in Cirrhotic Patients with Acute Kidney Injury.
    Dig Dis Sci. 2025 Feb 15. doi: 10.1007/s10620-025-08881.
    PubMed     Abstract available
    
    
    
38. HOLMAN A, Solano Q, Firn J, Tapper E, et al
    Clinical Ethics Consultations in Cirrhosis Care.
    Dig Dis Sci. 2025 Feb 8. doi: 10.1007/s10620-025-08866.
    PubMed     Abstract available
    
    
    
39. LI Y, Ma X, Cui S, Jiang G, et al
    Association Between Serum Uric Acid and Non-alcoholic Fatty Liver Disease in Non-obese Young Population: A Prospective Cohort Study.
    Dig Dis Sci. 2025;70:825-834.
    PubMed     Abstract available
    
    
    
40. CHO EEL, Law M, Yu Z, Yong JN, et al
    Artificial Intelligence and Machine Learning Predicting Transarterial Chemoembolization Outcomes: A Systematic Review.
    Dig Dis Sci. 2025;70:533-542.
    PubMed     Abstract available
    
    
    
41. MALANDRIS K, Korakas E, Sarakapina A, Kalopitas G, et al
    Accuracy of Controlled Attenuation Parameter for Liver Steatosis in High-Risk Patients for MASLD Using MRI-Proton Density Fat Fraction as Reference Standard.
    Dig Dis Sci. 2025;70:814-824.
    PubMed     Abstract available
    
    
    
42. COMAN D, Bilodeau M, Vincent C, Brochiero E, et al
    Integration of Non-invasive Screening for Cystic Fibrosis Related Liver Disease in the Regular Follow-Up for Cystic Fibrosis.
    Dig Dis Sci. 2025;70:526-532.
    PubMed     Abstract available
    
    
    
43. SINGH V, De A, Aggrawal R, Singh A, et al
    Safety and Efficacy of Dapagliflozin in Recurrent Ascites: A Pilot Study.
    Dig Dis Sci. 2025;70:835-842.
    PubMed     Abstract available
    
    
    January 2025
44. BISWAS S, Lo GH, Mehta S, Elhence A, et al
    Abbreviated Duration of Vasoactive Agents Has Similar Outcomes as Standard Duration of Therapy in Patients with Liver Cirrhosis and Variceal Bleeding: An Individual Patient Data Meta-Analysis.
    Dig Dis Sci. 2025 Jan 27. doi: 10.1007/s10620-025-08851.
    PubMed     Abstract available
    
    
    
45. SHIN IS, Moon JH, Lee YN, Park JW, et al
    Re-intervention Utility After Endoscopic Ultrasound-Guided Hepaticogastrostomy Using a Partially Covered Stent with Anchoring Flange.
    Dig Dis Sci. 2025 Jan 27. doi: 10.1007/s10620-025-08852.
    PubMed     Abstract available
    
    
    
46. GALLACHER J, Tavabie OD
    Use of Physical Restraints for Patients with Hepatic Encephalopathy - Why We Should Restrain Our Enthusiasm.
    Dig Dis Sci. 2025 Jan 13. doi: 10.1007/s10620-024-08830.
    PubMed    
    
    
    
47. NJEI B, Mezzacappa C, John BV, Serper M, et al
    Mortality, Hepatic Decompensation, and Cardiovascular Outcomes in Lean vs. Non-lean MASLD Cirrhosis: A Veterans Affairs Cohort Study.
    Dig Dis Sci. 2025 Jan 8. doi: 10.1007/s10620-024-08764.
    PubMed     Abstract available
    
    
    
48. GU J, Cao Z, Niu G, Ying J, et al
    Clinical Significance of Acyl-CoA Dehydrogenase Short Chain and Its Anti-tumor Role in Hepatocellular Carcinoma by Inhibiting Canonical Wnt/beta-Catenin Pathway.
    Dig Dis Sci. 2025 Jan 2. doi: 10.1007/s10620-024-08813.
    PubMed     Abstract available
    
    
    
49. SANG H, Lim J, Kim HI
    Association of Comorbidity Duration with the Occurrence and Prognosis of Steatotic Liver Disease.
    Dig Dis Sci. 2025;70:386-398.
    PubMed     Abstract available
    
    
    
50. BOLLINGER B, Cotter R, Deng Y, Ilagan-Ying Y, et al
    Presence of Mood and/or Anxiety Disorders Does Not Affect Success of Weight Management Therapies in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Dig Dis Sci. 2025;70:378-385.
    PubMed     Abstract available
    
    
    
51. CELAJ S, Estevez J, Novelli P, Orons P, et al
    Challenges and Opportunities in the Adoption of p-TIPS for Acute Variceal Bleeding: Insights from a US Tertiary Center.
    Dig Dis Sci. 2025;70:399-405.
    PubMed     Abstract available
    
    
    
52. MILLER KC, Geyer B, Alexopoulos AS, Moylan CA, et al
    Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review.
    Dig Dis Sci. 2025;70:154-167.
    PubMed     Abstract available
    
    
    December 2024
53. YAKOVCHENKO V, Chang MF, Hernaez R, Awad JA, et al
    Access to Evaluation for Liver Transplantation in the Veterans Health Administration.
    Dig Dis Sci. 2024 Dec 11. doi: 10.1007/s10620-024-08717.
    PubMed     Abstract available
    
    
    
54. ZOU H, Zhou XL, Liu W
    Hepatic Echinococcosis with Intrapulmonary Metastases.
    Dig Dis Sci. 2024 Dec 2. doi: 10.1007/s10620-024-08768.
    PubMed    
    
    
    
55. CUMPIAN NA, Choi G, Saab S
    Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis.
    Dig Dis Sci. 2024 Dec 2. doi: 10.1007/s10620-024-08742.
    PubMed     Abstract available
    
    
    
56. LIN Y, Ye H, Chen Y, Zhang R, et al
    Integrative Analyses of Genes of Pediatric Non-alcoholic Fatty Liver Disease Associated with Energy Metabolism.
    Dig Dis Sci. 2024;69:4373-4391.
    PubMed     Abstract available
    
    
    November 2024
57. LOYOLA-VELEZ AJ, John BV
    SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks.
    Dig Dis Sci. 2024 Nov 24. doi: 10.1007/s10620-024-08703.
    PubMed    
    
    
    
58. ALI YO, Goble SR, Leventhal TM
    Disparities and Outcomes of Physical Restraint Use in Hepatic Encephalopathy: A National Inpatient Assessment.
    Dig Dis Sci. 2024 Nov 24. doi: 10.1007/s10620-024-08758.
    PubMed     Abstract available
    
    
    
59. XIAO Y, Shi M, Xiao J, Xie X, et al
    Dynamic Profiles of Internal m7G Methylation on mRNAs in the Progression from HBV Infection to Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Nov 18. doi: 10.1007/s10620-024-08736.
    PubMed     Abstract available
    
    
    
60. TANG S, He L, Huang T, Zeng Y, et al
    Hepatic Amyloidosis Without Hepatomegaly.
    Dig Dis Sci. 2024 Nov 18. doi: 10.1007/s10620-024-08731.
    PubMed    
    
    
    
61. VERMA M, Chan M, Toroghi S, Gallagher M, et al
    Multimedia-Based Education Led to Improvement in Disease Knowledge Among Patients with Cirrhosis.
    Dig Dis Sci. 2024 Nov 7. doi: 10.1007/s10620-024-08704.
    PubMed     Abstract available
    
    
    
62. GOYAL T, Song MW, Suresh D, Jasty VSJ, et al
    Serial Liver Stiffness Measurement and Fibrosis-4 Scores in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Dig Dis Sci. 2024;69:4250-4258.
    PubMed     Abstract available
    
    
    
63. JASTY VSJ, Urias E, Le Ashley Tiong K, Aboona MB, et al
    Prognostic Accuracy of Transient Elastography-Based Predictors in Diabetes and Obesity: A Multicenter International Cohort Study.
    Dig Dis Sci. 2024;69:4240-4249.
    PubMed     Abstract available
    
    
    October 2024
64. LIU ZW, Song T, Wang ZH, Sun LL, et al
    Predicting Portal Pressure Gradient in Patients with Decompensated Cirrhosis: A Non-invasive Deep Learning Model.
    Dig Dis Sci. 2024 Oct 28. doi: 10.1007/s10620-024-08701.
    PubMed     Abstract available
    
    
    
65. SHI Y, Gu H, Yuan X, Qian L, et al
    A Case of Multisite Gastric Hepatoid Adenocarcinoma Mimicking Gastric Stromal Tumors.
    Dig Dis Sci. 2024 Oct 24. doi: 10.1007/s10620-024-08680.
    PubMed    
    
    
    
66. SINGAL AK, Reddy RK, Gudiwada MC, Jasti JJ, et al
    Hepatocellular Carcinoma in Acute Hepatic Porphyria: A Meta-Analysis of Observational Studies.
    Dig Dis Sci. 2024 Oct 22. doi: 10.1007/s10620-024-08661.
    PubMed     Abstract available
    
    
    
67. KAWADA T
    Screening Ability of Non-invasive Markers for Detecting Hepatic Fibrosis.
    Dig Dis Sci. 2024 Oct 5. doi: 10.1007/s10620-024-08668.
    PubMed    
    
    
    
68. JINDAL A, Kumar G, Sharma MK, Vashishtha C, et al
    Derivation of Splenic Stiffness in Subjects with Normal Liver Stiffness and No Vascular Liver Disease Using Transient Elastography with a Spleen-Dedicated Module: A Large Cross Sectional Study.
    Dig Dis Sci. 2024;69:3942-3951.
    PubMed     Abstract available
    
    
    
69. KUMARI K, Pahuja SK, Kumar S
    A Comprehensive Examination of ChatGPT's Contribution to the Healthcare Sector and Hepatology.
    Dig Dis Sci. 2024 Oct 1. doi: 10.1007/s10620-024-08659.
    PubMed     Abstract available
    
    
    September 2024
70. OHNO A, Fujimori N, Kaku T, Shimokawa Y, et al
    Feasibility of Endoscopic Ultrasound-Guided Hepaticogastrostomy for Malignant Hilar Biliary Obstruction.
    Dig Dis Sci. 2024 Sep 29. doi: 10.1007/s10620-024-08652.
    PubMed     Abstract available
    
    
    
71. REBILLARD E, De Abreu N, Buchard B, Muti L, et al
    AFP-DIAM Score to Predict Survival in Patients with Hepatocellular Carcinoma Before TACE: A French Multicenter Study.
    Dig Dis Sci. 2024 Sep 25. doi: 10.1007/s10620-024-08639.
    PubMed     Abstract available
    
    
    
72. PATEL KM, Zhang J, Marsden J, Bays C, et al
    Missed and Delayed Diagnoses of Chronic Liver Disease in Primary Care Patients with Cirrhosis.
    Dig Dis Sci. 2024 Sep 20. doi: 10.1007/s10620-024-08601.
    PubMed     Abstract available
    
    
    
73. RULE JA, Ajayi F, James LP, Tujios SR, et al
    Differentiating Ischemic Hepatitis from Acetaminophen Overdose in Acute Liver Failure: Role of Acetaminophen Adducts-Ischemic Hepatitis vs Acetaminophen Overdose.
    Dig Dis Sci. 2024 Sep 2. doi: 10.1007/s10620-024-08602.
    PubMed     Abstract available
    
    
    
74. SOLANO QP, Chen X, Parikh ND, Tapper EB, et al
    Racial and Ethnic Disparities in Outcomes After the Development of Ascites: A National Cohort Study.
    Dig Dis Sci. 2024;69:3214-3219.
    PubMed     Abstract available
    
    
    
75. FU CE, Teng M, Tung D, Ramadoss V, et al
    Sex and Race-Ethnic Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease: An Analysis of 40,166 Individuals.
    Dig Dis Sci. 2024;69:3195-3205.
    PubMed     Abstract available
    
    
    August 2024
76. DIAZ PM, Saly DL, Horick N, Petrosyan R, et al
    Prognosis of Transplant-Ineligible Patients with Cirrhosis and Acute Kidney Injury Who Initiate Renal Replacement Therapy.
    Dig Dis Sci. 2024 Aug 31. doi: 10.1007/s10620-024-08623.
    PubMed     Abstract available
    
    
    
77. HU Y, Zhou M, Liu D, Gong J, et al
    Risk Factors for Rebleeding After Endoscopic Injection of Cyanoacrylate Glue for Gastric Varices: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2024;69:2890-2903.
    PubMed     Abstract available
    
    
    
78. AGGARWAL N, Agarwal A, Alarouri H, Dwarakanathan V, et al
    Patients with Celiac Disease Have High Prevalence of Fatty Liver and Metabolic Syndrome.
    Dig Dis Sci. 2024;69:3029-3042.
    PubMed     Abstract available
    
    
    July 2024
79. IFRAH A, Fromer R, Gayner AH, Yeung HM, et al
    Discharge Outcomes of Hospitalized Patients with New Onset Decompensated Cirrhosis.
    Dig Dis Sci. 2024 Jul 31. doi: 10.1007/s10620-024-08574.
    PubMed     Abstract available
    
    
    
80. LEE DU, Bhowmick K, Althwanay A, Sandlow S, et al
    Etiology-Specific Effects of Impaired Functional Status on Liver Transplant Outcomes.
    Dig Dis Sci. 2024 Jul 16. doi: 10.1007/s10620-024-08522.
    PubMed     Abstract available
    
    
    
81. YAKUBU I, Flynn S, Khan H, Nguyen M, et al
    Burden of Portal Hypertension Complications Is Greater in Liver Transplant Wait-Listed Registrants with End-Stage Liver Disease and Type 2 Diabetes.
    Dig Dis Sci. 2024 Jul 10. doi: 10.1007/s10620-024-08499.
    PubMed     Abstract available
    
    
    
82. EDELSON JC, Rockey DC
    Safety of Endoscopy in Cirrhosis.
    Dig Dis Sci. 2024 Jul 8. doi: 10.1007/s10620-024-08539.
    PubMed     Abstract available
    
    
    
83. GUAN Y, Gan Y, An J
    Clinical Characteristics and Prognosis of Early-Onset Hepatocellular Carcinoma: A Retrospective Cohort Study Based on Population Data.
    Dig Dis Sci. 2024 Jul 4. doi: 10.1007/s10620-024-08549.
    PubMed     Abstract available
    
    
    
84. STERN C, Ngo A, Villela-Nogueira C, Thabut D, et al
    A Simple and Reliable 2D-Shear Wave Elastography and UltraSound Coefficient Attenuation Parameter Technique in Chronic Liver Diseases.
    Dig Dis Sci. 2024;69:2648-2654.
    PubMed     Abstract available
    
    
    June 2024
85. BROWN C, Hernandez R, Ford T, Aksan N, et al
    Inadequate Dietary Education and Poor Adherence to a High Protein, Low Sodium Diet in Cirrhosis: Mixed Methods Approach.
    Dig Dis Sci. 2024 Jun 28. doi: 10.1007/s10620-024-08526.
    PubMed     Abstract available
    
    
    
86. YANG JO, Chittajallu P, Benhammou JN, Patel A, et al
    Validation of a Machine Learning Algorithm, EVendo, for Predicting Esophageal Varices in Hepatocellular Carcinoma.
    Dig Dis Sci. 2024 Jun 19. doi: 10.1007/s10620-024-08449.
    PubMed     Abstract available
    
    
    
87. HANSEN S, Gilroy R, Lindsay I, Doty JR, et al
    A Meta-Analysis of Cumulative Incidence of Hepatocellular Carcinoma After the Fontan Operation.
    Dig Dis Sci. 2024 Jun 13. doi: 10.1007/s10620-024-08470.
    PubMed     Abstract available
    
    
    
88. FULLER SR, Schreiner AD
    Hepatic Fibrosis Risk Assessment in Primary Care: Opportunities and Challenges.
    Dig Dis Sci. 2024 Jun 6. doi: 10.1007/s10620-024-08498.
    PubMed    
    
    
    
89. SHIH HW, Lai Y, Hung HC, Lee JC, et al
    Liver Resection Criteria for Patients with Hepatocellular Carcinoma and Multiple Tumors Based on Total Tumor Volume.
    Dig Dis Sci. 2024 Jun 1. doi: 10.1007/s10620-024-08500.
    PubMed     Abstract available
    
    
    
90. JINDAL A, Singh H, Kumar G, Arora V, et al
    Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study).
    Dig Dis Sci. 2024;69:2204-2214.
    PubMed     Abstract available
    
    
    May 2024
91. ZHOU Y, Zhang Q, Kong Y, Guo X, et al
    Retraction Note: Insulin-Like Growth Factor Binding Protein-Related Protein 1 Activates Primary Hepatic Stellate Cells via Autophagy Regulated by the PI3K/Akt/mTOR Signaling Pathway.
    Dig Dis Sci. 2024 May 29. doi: 10.1007/s10620-024-08506.
    PubMed    
    
    
    
92. KOCH DG, Rockey DC, Litwin SS, Tedford RJ, et al
    H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure.
    Dig Dis Sci. 2024 May 23. doi: 10.1007/s10620-024-08438.
    PubMed     Abstract available
    
    
    
93. UFERE NN
    Increasing Healthcare System Empathy for Patients with Advanced Liver Disease: My Top 10 Lessons in Palliative Hepatology.
    Dig Dis Sci. 2024 May 4. doi: 10.1007/s10620-024-08406.
    PubMed    
    
    
    
94. PEMMASANI G, Tremaine W, Karagozian R, John S, et al
    Impact of Cirrhosis Etiology on the Risk for Venous Thromboembolism.
    Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08440.
    PubMed     Abstract available
    
    
    
95. THRIFT AP, Nguyen Wenker TH, Godwin K, Balakrishnan M, et al
    An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients.
    Dig Dis Sci. 2024 May 3. doi: 10.1007/s10620-024-08437.
    PubMed     Abstract available
    
    
    
96. IM KH, Saeed WK, Kim EB, Lee AH, et al
    Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis.
    Dig Dis Sci. 2024;69:1701-1713.
    PubMed     Abstract available
    
    
    
97. DONG Y, Xu H, Zhang Z, Zhou Z, et al
    A Novel Nomogram for Predicting Early Rebleeding After Endoscopic Treatment of Esophagogastric Variceal Hemorrhage.
    Dig Dis Sci. 2024;69:1852-1862.
    PubMed     Abstract available
    
    
    April 2024
98. TAN C, Zeng X, Guo X, Mo M, et al
    A Novel lncRNA lncRNA-4045 Promotes the Progression of Hepatocellular Carcinoma by Affecting the Expression of AKR1B10.
    Dig Dis Sci. 2024 Apr 25. doi: 10.1007/s10620-024-08383.
    PubMed     Abstract available
    
    
    
99. MARCANTEI C, Couret A, King J, Mazeaud S, et al
    Effects of Exercise Training on Muscle Mass and Physical Function in Patients with Hepatocellular Carcinoma After Diagnosis: A Systematic Review.
    Dig Dis Sci. 2024 Apr 25. doi: 10.1007/s10620-024-08441.
    PubMed     Abstract available
    
    
    
100. HSIEH HC, Chang WP, Huang PJ, Wang CH, et al
     Effectiveness of Exercise Interventions on Body Composition, Exercise Capacity, Fatigue, and Quality of Life in Patients with Liver Cirrhosis: A Meta-Analysis of Randomized Controlled Trials.
     Dig Dis Sci. 2024 Apr 24. doi: 10.1007/s10620-024-08447.
     PubMed     Abstract available
     
     
     
101. HORBAL SR, Belancourt PX, Zhang P, Holcombe SA, et al
     Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08450.
     PubMed     Abstract available
     
     
     
102. CHANG ML, Le PH, Chen WT, Chen TD, et al
     Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08439.
     PubMed     Abstract available
     
     
     
103. ZHANG X, Wang W, Mo S, Sun X, et al
     DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08401.
     PubMed     Abstract available
     
     
     
104. MOON AM, Swier RM, Lane LM, Barritt AS 4th, et al
     Statewide Survey of Primary Care and Subspecialty Providers on Hepatocellular Carcinoma Risk-Stratification and Surveillance Practices.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08442.
     PubMed     Abstract available
     
     
     
105. MANNING ME, Fricker Z
     Cardiopulmonary Resuscitation Outcomes and Trainee Perception of Code Status Discussions in Patients with Cirrhosis.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08443.
     PubMed     Abstract available
     
     
     
106. TWOHIG PA, Peeraphatdit TB, Samson K, Schissel M, et al
     A Prospective Multimodal Education Intervention for Providers Does Not Increase Hepatic Encephalopathy Treatment Rates.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08445.
     PubMed     Abstract available
     
     
     
107. WEBER S, Unger K, Alunni-Fabbroni M, Hirner-Eppeneder H, et al
     Metabolomic Analysis of Human Cirrhosis and Hepatocellular Carcinoma: A Pilot Study.
     Dig Dis Sci. 2024 Apr 23. doi: 10.1007/s10620-024-08446.
     PubMed     Abstract available
     
     
     
108. MCCURDY H, Nobbe A, Scott D, Patton H, et al
     Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration.
     Dig Dis Sci. 2024 Apr 14. doi: 10.1007/s10620-024-08409.
     PubMed     Abstract available
     
     
     
109. PEARLMAN BL
     Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
     Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
     PubMed     Abstract available
     
     
     
110. KHAMSEH ME, Malek M, Jahangiri S, Nobarani S, et al
     Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis.
     Dig Dis Sci. 2024;69:1430-1443.
     PubMed     Abstract available
     
     
     
111. POP A, Halegoua-DeMarzio D, Barnhart H, Kleiner D, et al
     Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical Presentations.
     Dig Dis Sci. 2024;69:1479-1487.
     PubMed     Abstract available
     
     
     
112. WILLIAMS EE, Mladenovic A, Ranginani D, Weber R, et al
     Role of Spleen Stiffness Measurement in the Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease.
     Dig Dis Sci. 2024;69:1444-1453.
     PubMed     Abstract available
     
     
     
113. BEHARI J
     Spleen Stiffness Measurement in Metabolic Dysfunction-Associated Steatotic Liver Disease-Value Added or Work in Progress?
     Dig Dis Sci. 2024;69:1093-1095.
     PubMed    
     
     
     March 2024
114. WANG H, Liu X, Xie Y, Qin X, et al
     A Case of Immunoglobulin Light Chain Hepatic Amyloidosis with Abdominal Hematoma.
     Dig Dis Sci. 2024 Mar 30. doi: 10.1007/s10620-024-08342.
     PubMed    
     
     
     
115. JAFRI F, Saad S, Riaz H, Saleem F, et al
     Lack of Diversity in Transplant Hepatology Fellowship Program Directorship.
     Dig Dis Sci. 2024 Mar 23. doi: 10.1007/s10620-024-08388.
     PubMed     Abstract available
     
     
     
116. ARSHAD T, Vainer D, Khan H, Baral A, et al
     Development of Clinical Algorithm Utilizing Vibration-Controlled Transient Elastography to Detect Advanced Hepatic Fibrosis in Liver Transplant Recipients.
     Dig Dis Sci. 2024 Mar 18. doi: 10.1007/s10620-024-08366.
     PubMed     Abstract available
     
     
     
117. KAHN-BOESEL O, Mitchell H, Li L, Zhu E, et al
     Hospital-Level Care at Home for Patients with Cirrhosis.
     Dig Dis Sci. 2024 Mar 11. doi: 10.1007/s10620-024-08361.
     PubMed     Abstract available
     
     
     
118. PETROSYAN R, Endres P, Ufere NN, St Hillien SA, et al
     Healthcare Resource Utilization and Goals of Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
     Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08317.
     PubMed     Abstract available
     
     
     
119. PATEL AA, Walling A, Bansal A
     A New Look at Goals-of-Care Discussions in Patients with Cirrhosis and Acute Kidney Injury.
     Dig Dis Sci. 2024 Mar 7. doi: 10.1007/s10620-024-08300.
     PubMed    
     
     
     
120. REN J, Yao X, Yang M, Cheng S, et al
     Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma.
     Dig Dis Sci. 2024 Mar 6. doi: 10.1007/s10620-024-08321.
     PubMed     Abstract available
     
     
     
121. KIM RG, Patel S, Satre DD, Shumway M, et al
     Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease.
     Dig Dis Sci. 2024;69:732-742.
     PubMed     Abstract available
     
     
     
122. JAROENLAPNOPPARAT A, Mettler SK, Guillen H, Chayanupatkul M, et al
     Changes in the Prevalence, Incidence, and Disability-Adjusted Life Years of Non-alcoholic Fatty Liver Disease in the United States Between 1990 and 2019.
     Dig Dis Sci. 2024;69:702-712.
     PubMed     Abstract available
     
     
     
123. VASSILOPOULOS A, Kalligeros M, Vassilopoulos S, Shehadeh F, et al
     Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis.
     Dig Dis Sci. 2024;69:989-1003.
     PubMed     Abstract available
     
     
     
124. SADLIK G, Anderson RC, Lei X, Cen SY, et al
     Pseudocirrhosis: A Case Series with Clinical and Radiographic Correlation and Review of the Literature.
     Dig Dis Sci. 2024;69:1004-1014.
     PubMed     Abstract available
     
     
     February 2024
125. KALAITZAKIS ZE, Giahnakis E, Koutroubakis IE, Mouzas IA, et al
     Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study.
     Dig Dis Sci. 2024 Feb 27. doi: 10.1007/s10620-023-08223.
     PubMed     Abstract available
     
     
     
126. ZHAO X, Guo X, Zhao Y, Yu Y, et al
     Gastrointestinal Bleeding Was Diagnosed as Small Intestinal Metastasis of Hepatocellular Carcinoma by Double-Balloon Enteroscopy.
     Dig Dis Sci. 2024 Feb 21. doi: 10.1007/s10620-024-08339.
     PubMed    
     
     
     
127. YE N, Shi X, Gao J, Dong R, et al
     Exosomes from Intrahepatic Cholestasis of Pregnancy Induce Cell Apoptosis Through the miRNA-6891-5p/YWHAE Pathway.
     Dig Dis Sci. 2024 Feb 15. doi: 10.1007/s10620-023-08265.
     PubMed     Abstract available
     
     
     
128. GU Y, Chen G, Ning X
     Homeobox Protein BarH-like 1 Promotes Gastric Cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178.
     Dig Dis Sci. 2024 Feb 15. doi: 10.1007/s10620-024-08312.
     PubMed     Abstract available
     
     
     
129. ARE VS, Gromski MA, Akisik F, Vilar-Gomez E, et al
     Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis.
     Dig Dis Sci. 2024 Feb 12. doi: 10.1007/s10620-023-08260.
     PubMed     Abstract available
     
     
     
130. MUKUND A, Aravind A, Jindal A, Tevethia HV, et al
     Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis.
     Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08256.
     PubMed     Abstract available
     
     
     
131. YILMAZ L, Bulut A, Aytekin A, Baskonus I, et al
     A Novel Technique for the Management of Persistent Biliary Fistulas Developing After Liver Hydatid Cyst Surgeries: Drain Clamping Technique.
     Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-024-08284.
     PubMed     Abstract available
     
     
     
132. LI R, Sarin S
     Disparity Among African Americans in Transjugular Intrahepatic Portosystemic Shunt Procedure: A National Inpatient Sample Analysis from 2015 to 2020.
     Dig Dis Sci. 2024 Feb 6. doi: 10.1007/s10620-024-08273.
     PubMed     Abstract available
     
     
     
133. BATSAIKHAN B, Dai CY
     Treatment of Hepatocellular Carcinoma in the Elderly: Slash or Burn?
     Dig Dis Sci. 2024 Feb 1. doi: 10.1007/s10620-023-08247.
     PubMed    
     
     
     
134. KIM JI, Lee J, Choi GH, Lee MW, et al
     Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma.
     Dig Dis Sci. 2024 Feb 1. doi: 10.1007/s10620-023-08245.
     PubMed     Abstract available
     
     
     
135. ZEREM E, Denjagic Basic M, Kurtcehajic A, Zerem D, et al
     Indications for the Use of Endoscopic Ultrasound-Guided Liver Biopsy in Patients with Liver Fibrosis.
     Dig Dis Sci. 2024;69:643-644.
     PubMed    
     
     
     
136. ASHKTORAB H, Challa SR, Singh G, Nanduri S, et al
     Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study.
     Dig Dis Sci. 2024;69:562-569.
     PubMed     Abstract available
     
     
     
137. WAJSBROT NB, Leite NC, Franca PHC, Cardoso CRL, et al
     Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2024;69:634-642.
     PubMed     Abstract available
     
     
     
138. FIGUEROA G, Castaneda S, McLean H, Dukandar J, et al
     Low Health Literacy, Lack of Knowledge, and Self-Control Hinder Healthy Lifestyles in Diverse Patients with Steatotic Liver Disease.
     Dig Dis Sci. 2024;69:384-398.
     PubMed     Abstract available
     
     
     
139. BEHARI J, Bradley A, Townsend K, Becich MJ, et al
     Limitations of Noninvasive Tests-Based Population-Level Risk Stratification Strategy for Nonalcoholic Fatty Liver Disease.
     Dig Dis Sci. 2024;69:370-383.
     PubMed     Abstract available
     
     
     January 2024
140. HUANG FD, Zhong YP, Sun GY, Xu QJ, et al
     Fanconi Anemia Complementary Group A (FANCA) Facilitates the Occurrence and Progression of Liver Hepatocellular Carcinoma.
     Dig Dis Sci. 2024 Jan 28. doi: 10.1007/s10620-024-08282.
     PubMed     Abstract available
     
     
     
141. ASADA S, Namisaki T, Kaji K, Takaya H, et al
     VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis.
     Dig Dis Sci. 2024 Jan 20. doi: 10.1007/s10620-023-08257.
     PubMed     Abstract available
     
     
     
142. BOWMAN CA, Bichoupan K, Posner S, Schonfeld E, et al
     A Prospective Open-Label Dose-Response Study to Correct Vitamin D Deficiency in Cirrhosis.
     Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08224.
     PubMed     Abstract available
     
     
     
143. TSAI SY, O'Leary JG
     Optimizing Outcomes in Patients with Ascites Complicating Cirrhosis-Maximizing the Hour of Power.
     Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08255.
     PubMed    
     
     
     
144. BADAL J, Badal B, Nawras M, Lee-Smith W, et al
     Diagnostic Paracentesis Within 1 Day Is Associated With Reduced Mortality and Length of Hospital Stay in Patients with Cirrhosis and Ascites.
     Dig Dis Sci. 2024 Jan 13. doi: 10.1007/s10620-023-08249.
     PubMed     Abstract available
     
     
     
145. LIN W, Zhao Z, Du W, Ni Z, et al
     Interferon-Gamma-Inducible Protein 16 Inhibits Hepatocellular Carcinoma via Interferon Regulatory Factor 3 on Chemosensitivity.
     Dig Dis Sci. 2024 Jan 3. doi: 10.1007/s10620-023-08175.
     PubMed     Abstract available
     
     
     
146. BLOOM PP, Che Z, Hyde A, Johnson E, et al
     Development and Evaluation of a Patient Cirrhosis Knowledge Assessment.
     Dig Dis Sci. 2024 Jan 3. doi: 10.1007/s10620-023-08238.
     PubMed     Abstract available
     
     
     December 2023
147. JAMES M, Alazawi W
     Non-invasive Tests of Fibrosis: Does One Size Fit All?
     Dig Dis Sci. 2023;68:4285-4286.
     PubMed    
     
     
     
148. ARORA U, Goyal RM, Teh KKJ, Pei Y, et al
     Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.
     Dig Dis Sci. 2023;68:4485-4498.
     PubMed     Abstract available
     
     
     November 2023
149. SUN Y, Lu M, Feldman R, Saul M, et al
     Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.
     Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08183.
     PubMed     Abstract available
     
     
     
150. SOHAL A, Kohli I, Chaudhry H, Singh I, et al
     Vaccine-Preventable Illness Leads to Adverse Outcomes in Liver Transplant Recipients.
     Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08202.
     PubMed     Abstract available
     
     
     
151. WONG ZY, Koh JH, Muthiah M, Koh B, et al
     Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
     Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08150.
     PubMed     Abstract available
     
     
     
152. LOW EXS, Wang YP, Lu CL
     Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications.
     Dig Dis Sci. 2023 Nov 15. doi: 10.1007/s10620-023-08153.
     PubMed     Abstract available
     
     
     October 2023
153. JINDAL A, Sharma MK, Vijayaraghavan R, Sm S, et al
     Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis.
     Dig Dis Sci. 2023 Oct 31. doi: 10.1007/s10620-023-08144.
     PubMed     Abstract available
     
     
     
154. GONZALEZ HC, Trudeau S
     COVID-19 + Cirrhosis = Excess Hospital Confinement, Excess Casualties.
     Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08106.
     PubMed    
     
     
     
155. TWOHIG PA, Scholten K, Schissel M, Brittan K, et al
     Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic.
     Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08105.
     PubMed     Abstract available
     
     
     
156. BANGARU S, Sundaresh R, Lee A, Prause N, et al
     Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records.
     Dig Dis Sci. 2023 Oct 21. doi: 10.1007/s10620-023-08043.
     PubMed     Abstract available
     
     
     
157. KILANI Y, Kamal SAF, Vikash F, Vikash S, et al
     Correction to: Racial Disparities in Liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.
     Dig Dis Sci. 2023 Oct 13. doi: 10.1007/s10620-023-08131.
     PubMed    
     
     
     
158. WANG L, Zhang Y, Li J, Guo S, et al
     A Nomogram of Magnetic Resonance Imaging for Preoperative Assessment of Microvascular Invasion and Prognosis of Hepatocellular Carcinoma.
     Dig Dis Sci. 2023 Oct 4. doi: 10.1007/s10620-023-08022.
     PubMed     Abstract available
     
     
     
159. DAKROUB A, Anouti A, Cotter TG, Lee WM, et al
     Mortality and Morbidity Among Adult Liver Retransplant Recipients.
     Dig Dis Sci. 2023;68:4039-4049.
     PubMed     Abstract available
     
     
     
160. KAUR P, Verma N, Valsan A, Garg P, et al
     Prevalence, Risk Factors, and Impact of Bacterial or Fungal Infections in Acute Liver Failure Patients from India.
     Dig Dis Sci. 2023;68:4022-4038.
     PubMed     Abstract available
     
     
     
161. SMAYRA K, Miangul S, Yap N, Shi A, et al
     Technical Success, Sample Adequacy, and Complications of Pediatric Transjugular Liver Biopsy: A Systematic Review and Meta-Analysis.
     Dig Dis Sci. 2023;68:3846-3856.
     PubMed     Abstract available
     
     
     
162. LI R, Li M, Bidulescu A, Fly AD, et al
     Diets with Higher Anti-inflammatory Potential Associated with Lower Risk of Development of Nonalcoholic Fatty Liver Disease and Early-Stage of Fibrosis Among US Adults.
     Dig Dis Sci. 2023;68:4009-4021.
     PubMed     Abstract available
     
     
     September 2023
163. GOBLE S, Akambase J, Prieto J, Balderramo D, et al
     MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort.
     Dig Dis Sci. 2023 Sep 8. doi: 10.1007/s10620-023-08104.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.